| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 130, 2528-2534, Copyright © 1992 by Endocrine Society
ARTICLES |
LR Chaudhary, TC Spelsberg and BL Riggs
Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota 55905.
We investigated, in five cell strains per experiment, whether several cytokines known or believed to have effects on bone resorption were produced by nearly homogeneous strains of cultured normal human osteoblast-like (hOB) cells that display virtually the complete phenotype of the mature osteoblast. In unstimulated hOB cells, we detected constitutive production of interleukin-6 (IL-6) (mean +/- SE, 122 +/- 32 pg/ml) and IL-8 (135 +/- 39 pg/ml), but not of IL-4, granulocyte-macrophage colony-stimulating factor (GM-CSF), or tumor necrosis factor-alpha (TNF alpha). IL-1 beta in doses from 1-100 U/ml stimulated dose-dependent increases in IL-6 (r = 0.87; P less than 0.001) and IL-8 (r = 0.95; P less than 0.001). Similar increases occurred after stimulation with TNF alpha in doses from 3-300 U/ml. IL- 1 beta and TNF alpha also stimulated GM-CSF production, but only at higher doses. 17 beta-Estradiol (10(-8) M) had no significant effect on the secretion of any of these cytokines, either constitutively or after stimulation with IL-1 beta or TNF alpha. Stimulated production of IL-4 was not detected after treatment with IL-1 beta or TNF alpha, and that of TNF alpha was not detected after treatment with IL-1 beta. We conclude that IL-6, IL-8, and GM-CSF, but not IL-4 and TNF alpha, are produced by highly differentiated normal human cells of the osteoblast lineage, but their secretion is not regulated by estrogen. However, we cannot exclude the possibility that estrogen regulation of these cytokines may occur during early stages of osteoblast differentiation.
This article has been cited by other articles:
![]() |
K. M. Wright and J. S. Friedland Regulation of monocyte chemokine and MMP-9 secretion by proinflammatory cytokines in tuberculous osteomyelitis J. Leukoc. Biol., June 1, 2004; 75(6): 1086 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Schrum, I. Marriott, B. R. Butler, E. K. Thomas, M. C. Hudson, and K. L. Bost Functional CD40 Expression Induced following Bacterial Infection of Mouse and Human Osteoblasts Infect. Immun., March 1, 2003; 71(3): 1209 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bouchard, R. de Medicis, A. Lussier, P. H. Naccache, and P. E. Poubelle Inflammatory Microcrystals Alter the Functional Phenotype of Human Osteoblast-Like Cells In Vitro: Synergism with IL-1 to Overexpress Cyclooxygenase-2 J. Immunol., May 15, 2002; 168(10): 5310 - 5317. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sofat and A. Keat Alcohol intake in rheumatic disease: good or bad? Rheumatology, February 1, 2002; 41(2): 125 - 128. [Full Text] [PDF] |
||||
![]() |
G.-Q. Yao, B.-h. Sun, K. L. Insogna, and E. C. Weir Nuclear Factor-{kappa}B p50 Is Required for Tumor Necrosis Factor-{alpha}-Induced Colony-Stimulating Factor-1 Gene Expression in Osteoblasts Endocrinology, August 1, 2000; 141(8): 2914 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Azuma, K. Kaji, R. Katogi, S. Takeshita, and A. Kudo Tumor Necrosis Factor-alpha Induces Differentiation of and Bone Resorption by Osteoclasts J. Biol. Chem., February 18, 2000; 275(7): 4858 - 4864. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. V. N. Bodine, H. A. Harris, and B. S. Komm Suppression of Ligand-Dependent Estrogen Receptor Activity by Bone-Resorbing Cytokines in Human Osteoblasts Endocrinology, June 1, 1999; 140(6): 2439 - 2451. [Abstract] [Full Text] |
||||
![]() |
N. Ahmed, M.A. Khokher, and H.T. Hassan Cytokine-Induced Expansion of Human CD34+ Stem/Progenitor and CD34+CD41+ Early Megakaryocytic Marrow Cells Cultured on Normal Osteoblasts Stem Cells, March 1, 1999; 17(2): 92 - 99. [Abstract] [Full Text] |
||||
![]() |
C. K. Ritchie, L. R. Andrews, K. G. Thomas, D. J. Tindall, and L. A. Fitzpatrick The Effects of Growth Factors Associated with Osteoblasts on Prostate Carcinoma Proliferation and Chemotaxis: Implications for the Development of Metastatic Disease Endocrinology, March 1, 1997; 138(3): 1145 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Taichman, M. J. Reilly, R. S. Verma, and S. G. Emerson Augmented Production of Interleukin-6 by Normal Human Osteoblasts in Response to CD34+ Hematopoietic Bone Marrow Cells In Vitro Blood, February 15, 1997; 89(4): 1165 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ghazali, V. Fuentes, C. Desaint, P. Bataille, A. Westeel, M. Brazier, L. Prin, and A. Fournier Low Bone Mineral Density and Peripheral Blood Monocyte Activation Profile in Calcium Stone Formers with Idiopathic Hypercalciuria J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 32 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Chaudhary and L. V. Avioli Regulation of Interleukin-8 Gene Expression by Interleukin-1beta , Osteotropic Hormones, and Protein Kinase Inhibitors in Normal Human Bone Marrow Stromal Cells J. Biol. Chem., July 12, 1996; 271(28): 16591 - 16596. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Manolagas and R. L. Jilka Bone Marrow, Cytokines, and Bone Remodeling -- Emerging Insights into the Pathophysiology of Osteoporosis N. Engl. J. Med., February 2, 1995; 332(5): 305 - 311. [Full Text] [PDF] |
||||
![]() |
M. Horowitz Cytokines and estrogen in bone: anti-osteoporotic effects Science, April 30, 1993; 260(5108): 626 - 627. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |